Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance

By Zanger Ulrich M   Klein Kathrin   Saussele Tanja   Blievernicht Julia   H Hofmann Marco   Schwab Matthias  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 743-759

Future Medicine

Access to resources Recommend Favorite

The Functional Role of CYP2B6 in Human Drug Metabolism: Substrates and Inhibitors In Vitro, In Vivo and In Silico

By  

Current Drug Metabolism, Vol. 7, Iss. 7, 2006-10 ,pp. : 705-714

Bentham Science Publishers

Access to resources Recommend Favorite

Concurrent use of celecoxib and CYP2D6 substrates common

By  

Inpharma, Vol. 1, Iss. 1503, 2005-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Pharmacophore, QSAR, and Binding Mode Studies of Substrates of Human Cytochrome P450 2D6 (CYP2D6) Using Molecular Docking and Virtual Mutations and an Application to Chinese Herbal Medicine Screening

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 9, 2012-07 ,pp. : 1640-1704

Bentham Science Publishers

Access to resources Recommend Favorite

Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes

By  

Drug Metabolism Letters, Vol. 10, Iss. 1, 2016-03 ,pp. : 56-64

Bentham Science Publishers

Access to resources Recommend Favorite